These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19287301)

  • 21. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.
    Draenert R; Verrill CL; Tang Y; Allen TM; Wurcel AG; Boczanowski M; Lechner A; Kim AY; Suscovich T; Brown NV; Addo MM; Walker BD
    J Virol; 2004 Jan; 78(2):630-41. PubMed ID: 14694094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structured observations reveal slow HIV-1 CTL escape.
    Roberts HE; Hurst J; Robinson N; Brown H; Flanagan P; Vass L; Fidler S; Weber J; Babiker A; Phillips RE; McLean AR; Frater J;
    PLoS Genet; 2015 Feb; 11(2):e1004914. PubMed ID: 25642847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription.
    Bansal A; Carlson J; Yan J; Akinsiku OT; Schaefer M; Sabbaj S; Bet A; Levy DN; Heath S; Tang J; Kaslow RA; Walker BD; Ndung'u T; Goulder PJ; Heckerman D; Hunter E; Goepfert PA
    J Exp Med; 2010 Jan; 207(1):51-9. PubMed ID: 20065064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.
    Kaufmann DE; Bailey PM; Sidney J; Wagner B; Norris PJ; Johnston MN; Cosimi LA; Addo MM; Lichterfeld M; Altfeld M; Frahm N; Brander C; Sette A; Walker BD; Rosenberg ES
    J Virol; 2004 May; 78(9):4463-77. PubMed ID: 15078927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
    Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
    AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
    Borthwick N; Lin Z; Akahoshi T; Llano A; Silva-Arrieta S; Ahmed T; Dorrell L; Brander C; Murakoshi H; Takiguchi M; Hanke T
    PLoS One; 2017; 12(4):e0176418. PubMed ID: 28448594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes.
    Honeyborne I; Prendergast A; Pereyra F; Leslie A; Crawford H; Payne R; Reddy S; Bishop K; Moodley E; Nair K; van der Stok M; McCarthy N; Rousseau CM; Addo M; Mullins JI; Brander C; Kiepiela P; Walker BD; Goulder PJ
    J Virol; 2007 Apr; 81(7):3667-72. PubMed ID: 17251285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection.
    Horton H; Frank I; Baydo R; Jalbert E; Penn J; Wilson S; McNevin JP; McSweyn MD; Lee D; Huang Y; De Rosa SC; McElrath MJ
    J Immunol; 2006 Nov; 177(10):7406-15. PubMed ID: 17082660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
    J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
    AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host genotype and time dependent antigen presentation of viral peptides: predictions from theory.
    Eccleston RC; Coveney PV; Dalchau N
    Sci Rep; 2017 Oct; 7(1):14367. PubMed ID: 29084996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
    Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 Subtype C gag-specific T-cell responses in relation to human leukocyte antigens in a diverse population of HIV-infected Ethiopians.
    Tsegaye A; Ran L; Wolday D; Petros B; Dorigo W; Piriou E; Messele T; Sanders E; Tilahun T; Eshetu D; Schuitemaker H; Coutinho RA; Miedema F; Borghans J; van Baarle D
    J Acquir Immune Defic Syndr; 2007 Aug; 45(4):389-400. PubMed ID: 17417101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines.
    Singh RA; Barry MA
    J Immunol; 2004 Oct; 173(7):4387-93. PubMed ID: 15383568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.
    Hayes P; Fernandez N; Ochsenbauer C; Dalel J; Hare J; King D; Black L; Streatfield C; Kakarla V; Macharia G; Makinde J; Price M; Hunter E; ; Gilmour J
    PLoS One; 2021; 16(11):e0260118. PubMed ID: 34788349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel HIV type 1 CRF01_AE cytotoxic T lymphocyte (CTL) epitope restricted by an HLA-Cw0602 allele and a novel HLA-A0206/peptide restriction.
    Kantakamalakul W; de Souza M; Bejrachandra S; Ampol S; Cox J; Sutthent R
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1271-82. PubMed ID: 17209771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
    López M; Soriano V; Lozano S; Martinez P; Sempere J; González-Lahoz J; Benito J
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):884-92. PubMed ID: 16989614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.